文献速递妇科产科

高级别卵巢浆液性癌免疫相关基因差异表达

Differential expression of immune related genes in high-grade ovarian serous carcinoma.
PubMed 文献 · Gynecol Oncol · 2020-01-07

本研究回顾性分析51例高级别浆液性卵巢癌(HGSC)标本的微阵列数据,筛选183个免疫/炎症反应相关基因与总生存(OS)的关联,并在TCGA及五个GSE数据集验证。Duke队列中110个探针组(对应83个基因)在长期与短期生存者间差异表达(校正p<0.05);TCGA中IL6R高表达与长期生存者一致相关(Duke q=0.022)并改善OS(p=0.015,HR=0.8)。GSE14764和GSE26712中13个基因显著且与Duke一致,但GSE荟萃分析无基因一致显著。

要点

  • IL6R高表达在Duke队列与长期生存相关(q=0.022),TCGA中改善OS(p=0.015,HR=0.8)。
  • Duke队列110个探针组(83个免疫/炎症基因)在长短期生存者间差异表达(校正p<0.05)。
  • GSE荟萃分析未发现一致且显著关联生存的基因。

核心结论

  • IL6R表达评估可能值得开展,因其在长期生存者中高表达并与晚期HGSC改善生存相关。
  • 其他候选基因也值得进一步探索以促进免疫肿瘤药物发现。

研究设计与样本

  • 回顾性研究分析51例HGSC标本的微阵列数据(Affymetrix HG-U133A)。
  • 先验构建183个免疫/炎症反应相关基因(对应279个探针组)进行筛选。
  • 外部验证使用TCGA卵巢数据集和五个GSE公开HGSC数据集。

主要发现

  • Duke数据中110个探针组(对应83个免疫/炎症相关基因)在长期与短期HGSC生存者肿瘤间差异表达(校正p<0.05)。
  • TCGA中IL6R一个探针高表达与长期生存者高表达一致(Duke q值=0.022)并改善OS(p值=0.015,HR=0.8)。
  • GSE14764(N=4)和GSE26712(N=9)数据集中13个基因有显著p值且与Duke数据一致。
  • GSE荟萃分析中无基因一致且显著与生存相关。

关键数值与推荐

  • 基因表达与OS关联使用logrank检验评估。
  • 多重检验在FDR框架内处理。
  • 差异表达标准为校正p<0.05。

临床怎么用

  • 基于IL6R在长期生存者中高表达及与改善生存的关联,可考虑评估IL6R表达。
  • 其他候选基因可用于免疫肿瘤药物发现的进一步探索。

局限性

  • GSE荟萃分析未发现一致且显著关联生存的基因。
  • 部分GSE数据集样本量小(GSE14764 N=4,GSE26712 N=9)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify novel immunologic targets and biomarkers associated with overall survival (OS) in high-grade serous ovarian cancer (HGSC). METHODS: In this retrospective study, microarray data from 51 HGSC specimens were analyzed (Affymetrix HG-U133A). A panel of 183 immune/inflammatory response related genes linked to 279 probe sets was constructed a priori and screened. Associations between gene expression and OS were assessed using logrank tests. Multiple testing was addressed within the False Discovery Rate (FDR) framework. For external validation, TCGA Ovarian dataset and five GSE publicly available HGSC datasets were evaluated. RESULTS: In Duke data, 110 probe sets linked to 83 immunologic/inflammatory-related genes were differentially expressed in tumors from long versus short-term HGSC survivors (adjusted p < 0.05). In TCGA, concordant with the results from the Duke discovery cohort, high expression of one probe (IL6R) demonstrated a consistent significance and concordant association with higher expression in long-term HGSC survivors (Duke q-value = 0.022) and improved OS in the TCGA dataset (p-value = 0.015, HR = 0.8). Thirteen genes in GSE14764 (N = 4) and GSE26712 (N = 9) datasets had significant p-values and consistent concordant with Duke Data. Despite the significant associations of gene expression and OS in the individual GSE datasets, in the GSE meta-analysis no genes were consistently concordant and significantly associated with survival. CONCLUSIONS: Evaluation of IL6R expression may be warranted based on higher expression in long-term survivors and association with improved survival in advanced HGSC. The other candidate genes may also be of worthy of further exploration to enhance immuno-oncology drug discovery.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Siamakpour-Reihani S, Cobb LP, Jiang C, et al. Differential expression of immune related genes in high-grade ovarian serous carcinoma. Gynecol Oncol. 2020. PMID: 31918995. doi:10.1016/j.ygyno.2019.12.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。